Yashraj Biotechnology Ltd

Biotechnology ResearchMaharashtra, India201-500 Employees

Yashraj Biotechnology Ltd. (YBL), established in 1999 and headquartered in Navi Mumbai, India, is a premier ISO 13485:2016 and ISO 9001:2015 certified manufacturer specializing in high-quality antigens and antibodies for the global In Vitro Diagnostics (IVD) industry. The company addresses the critical need for high-purity, native-state biomarkers to ensure the diagnostic accuracy of assays for life-threatening diseases. YBL’s extensive product portfolio includes native and recombinant antigens, as well as polyclonal and monoclonal antibodies, covering a wide range of clinical areas such as oncology, cardiovascular health, inflammation, infectious diseases, and metabolic disorders. Key offerings include gold-standard markers like CRP, Troponin I, NT-proBNP, PCT, and various Cancer Antigens (CA125, CA15-3, CA19-9). A standout feature of YBL is its unique access to massive volumes of diverse clinical samples through its vast network of hospitals in India, which enables the purification of native antigens from human sources like serum, plasma, ascitic and pleural fluids. This vertical integration supports a "bench-to-bedside" approach, ensuring that products are physiologically relevant and customer-validated. Operating from a 200,000 sq. ft. state-of-the-art manufacturing footprint spread across four different sites, YBL utilizes advanced platforms including mammalian and microbial expression systems, and a specialized goat polyclonal antibody facility. With over 25 years of expertise, YBL serves as a strategic partner to leading global IVD manufacturers, providing them with reliable, batch-to-batch consistent raw materials to drive diagnostic innovation and improve patient outcomes worldwide.

Sign up for free to view info

Email Format Employee directory